MENU
+Compare
BRSYF
Stock ticker: OTC
AS OF
Dec 1 closing price
Price
$8.50
Change
+$0.50 (+6.25%)
Capitalization
342.14M

BRSYF stock forecast, quote, news & analysis

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders... Show more

BRSYF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BRSYF with price predictions
Nov 28, 2025

BRSYF's Stochastic Oscillator is staying in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BRSYF just turned positive on November 24, 2025. Looking at past instances where BRSYF's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRSYF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.746) is normal, around the industry mean (63.271). P/E Ratio (53.125) is within average values for comparable stocks, (37.178). BRSYF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). BRSYF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (7.112) is also within normal values, averaging (35.282).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.77B. The market cap for tickers in the group ranges from 1.86K to 222.59B. ABT holds the highest valuation in this group at 222.59B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 8%. FZMD experienced the highest price growth at 205%, while FOFA experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -72%. For the same stocks of the Industry, the average monthly volume growth was -73% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 74
Price Growth Rating: 61
SMR Rating: 87
Profit Risk Rating: 92
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
BRSYF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
19 Hartum Street
Phone
+972 25824030
Employees
106
Web
https://www.brainsway.com